AbbVie Inc., Alma Lasers GmbH, AngioDynamics Inc., Bausch Health Co Inc., Boston Scientific Corp., Candela Corp, Cutera Inc., Cynosure LLC, El.

Source: https://www.prnewswire.com/news-releases/energy-based-non-invasive-medical-aesthetic-treatment-system-market-size-to-grow-by-usd-1-841-74-million-from-2022-to-2027-growth-driven-by-rising-awareness---technavio-301716666.html

BerganKDV Wealth Management LLC increased its holdings in shares of Boston Scientific Co. () by 44.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission.

Source: https://www.americanbankingnews.com/2023/07/16/bergankdv-wealth-management-llc-has-33000-stake-in-boston-scientific-co-nysebsx.html

Boston Scientific Co. has a 1 year low of $38.54 and a 1 year high of $55.38.

Source: https://www.etfdailynews.com/2023/09/28/cable-hill-partners-llc-sells-311-shares-of-boston-scientific-co-nysebsx/

Boston Scientific Co. has a twelve month low of $44.35 and a twelve month high of $56.90.

Source: https://www.dailypolitical.com/2023/12/23/boston-scientific-co-nysebsx-shares-bought-by-ritholtz-wealth-management.html

Boston Scientific has a 1-year low of $37.74 and a 1-year high of $55.38.

Source: https://www.etfdailynews.com/2023/09/24/boston-scientific-nysebsx-receives-buy-rating-from-needham-company-llc/

Boston Scientific stock opened at $52.12 on Thursday.

Source: https://www.americanbankingnews.com/2023/04/30/boston-scientific-nysebsx-price-target-raised-to-58-00.html

Brookstone Capital Management Lowers Stock Position in Boston Scientific Co.

Source: https://www.americanbankingnews.com/2023/09/23/ae-wealth-management-llc-purchases-26209-shares-of-masco-co-nysemas.html

BTIG Research upped their target price on Boston Scientific from $62.00 to $64.00 and gave the company a “buy” rating in a report on Thursday, September 21st.

Source: https://www.dailypolitical.com/2023/11/28/boston-scientific-co-nysebsx-shares-purchased-by-franklin-resources-inc.html

Canaccord Genuity Group increased their price objective on shares of Boston Scientific from $58.00 to $62.00 and gave the company a “buy” rating in a report on Friday, July 28th.

Source: https://www.etfdailynews.com/2023/09/02/boston-scientific-co-nysebsx-shares-sold-by-public-sector-pension-investment-board/

Cibc World Markets Corp’s holdings in Boston Scientific were worth $841,000 at the end of the most recent quarter.

Source: https://www.americanbankingnews.com/2023/02/25/cibc-world-markets-corp-decreases-stock-position-in-boston-scientific-co-nysebsx.html

Equities research analysts expect that Boston Scientific will post 1.93 earnings per share for the current year.

Source: https://www.americanbankingnews.com/2023/04/30/boston-scientific-nysebsx-price-target-raised-to-58-00.html

Finally, Nuveen Asset Management LLC boosted its position in shares of Boston Scientific by 10.9% during the 3rd quarter.

Source: https://www.americanbankingnews.com/2023/04/25/asset-management-one-co-ltd-sells-19097-shares-of-boston-scientific-co-nysebsx.html

For Q1 2023, Boston Scientific also recorded a 25.5% adjusted operated margin, while management guided for margin expansion (a goal of 26.5% adj. operating margin for 2023).

Source: https://seekingalpha.com/article/4598576-boston-scientific-expect-to-pay-a-premium-for-its-growth-attributes?source=feed_all_articles

FourThought Financial LLC boosted its holdings in Boston Scientific by 40.6% in the third quarter.

Source: https://www.etfdailynews.com/2023/03/17/cva-family-office-llc-has-39000-holdings-in-boston-scientific-co-nysebsx/

Harbor Investment Advisory LLC lifted its holdings in shares of Boston Scientific by 5.5% during the third quarter.

Source: https://www.etfdailynews.com/2023/01/23/avantax-advisory-services-inc-has-606000-stock-position-in-boston-scientific-co-nysebsx/

Hazlett Burt & Watson Inc. boosted its stake in shares of Boston Scientific by 56.7% during the 4th quarter.

Source: https://www.etfdailynews.com/2023/05/01/d-a-davidson-co-sells-371-shares-of-boston-scientific-co-nysebsx/

Householder Group Estate & Retirement Specialist LLC bought a new stake in Boston Scientific in the 1st quarter valued at $26,000.

Source: https://www.dailypolitical.com/2023/08/28/boston-scientific-nysebsx-downgraded-by-stocknews-com.html

On average, analysts forecast that Boston Scientific will post 1.9 earnings per share for the current year.

Source: https://www.americanbankingnews.com/2023/04/03/boston-scientific-co-nysebsx-short-interest-up-12-8-in-march.html

On average, equities research analysts forecast that Boston Scientific Co. will post 1.95 EPS for the current fiscal year.

Source: https://www.etfdailynews.com/2023/05/01/d-a-davidson-co-sells-371-shares-of-boston-scientific-co-nysebsx/

Raymond James upped their target price on shares of Boston Scientific from $48.00 to $54.00 in a report on Thursday, December 8th.

Source: https://www.americanbankingnews.com/2023/01/07/boston-scientific-co-nysebsx-shares-purchased-by-ballentine-partners-llc.html